• Tue news: Regeneron fails to block Eylea biosimilar. Inside the GLP-1 price war. Novartis inks $1B biobucks deal. UCB/Biogen lupus drug. Lilly Alzheimer’s drug approved in Japan. See more on our front page

The Areniacs have invaded our board...

Anonymous

Guest
The person or persons posting all this Belviq crap are not Eisai or Arena employees. They are what is affectionaly know as Areniacs. They're 'pumpers' long on ARNA who feel that there is some conspiracy by short sellers to derail the Eisai sales force. Look for more of their rants on here as the ARNA stock is struggling and for whatever reason the nut jobs are emotionally tied to a stock/company.

Take a read and you will understand were all of their mindless babble comes from:

http://www.thestreet.mobi/story/119...prescription-data.html?puc=yahoo&cm_ven=YAHOO
 

<